The PI3K-Akt signaling pathway is a classic cancer-promoting pathway, which plays an active role in the progression of multiple cancers including OV and many inhibitors of this pathway have been used in the clinical trials of the therapy for OV [27]. The gene discussed is AKT1; the disease is cancer.